BCAP activators comprise a specialized class of chemical compounds known for their ability to modulate the activity of B-cell adapter for PI3K (BCAP), a crucial signaling protein in immune cells, particularly B lymphocytes. BCAP plays a pivotal role in orchestrating intracellular signaling pathways initiated by various immune receptors, such as B-cell receptors (BCRs) and Toll-like receptors (TLRs). These activators are designed to selectively target and enhance the function of BCAP, thereby influencing the activation of downstream signaling cascades in immune cells. At the molecular level, BCAP activators typically work by binding to specific regions of the BCAP protein, potentially inducing conformational changes that promote its interaction with other signaling molecules, ultimately amplifying immune responses.
The study of BCAP activators is essential for gaining a deeper understanding of immune cell signaling and the intricate molecular events that govern immune responses. Research in this field primarily focuses on elucidating the precise molecular mechanisms by which these compounds impact BCAP's function and their downstream effects on immune cell activation. Understanding the role of BCAP activators contributes to our broader knowledge of immunology and the complex web of signaling pathways involved in immune cell activation and regulation. Moreover, these compounds provide valuable tools for researchers seeking to investigate the fine-tuned mechanisms that govern immune responses, ultimately advancing our understanding of the immune system's role in health and disease and offering potential insights into immunomodulation in various scientific and biomedical contexts.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PKC activators; might influence BCAP expression through B cell activation pathways. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
Bruton's tyrosine kinase inhibitor; could modulate BCAP expression by influencing BCR signaling. | ||||||
R788 | 901119-35-5 | sc-364597 sc-364597A | 2 mg 50 mg | $405.00 $4000.00 | 2 | |
Syk inhibitor; might modulate BCAP expression in relation to B cell receptor signaling. | ||||||
CAL-101 | 870281-82-6 | sc-364453 | 10 mg | $193.00 | 4 | |
PI3Kδ inhibitor; potential influence on BCAP expression due to its role in the PI3K pathway. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid that can modulate B cell responses; potential influence on BCAP. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor; might influence BCAP expression given its role in PI3K-related pathways. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
TLR4 agonist; could influence BCAP expression in the context of B cell activation. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
TLR7 agonist; might influence BCAP expression during B cell activation. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
Immunomodulatory; potential effects on BCAP expression in the context of B cell responses. | ||||||